[1]
“Evaluation of treatment of HER2 positive Breast cancer patients with Trastuzumab combined with cytotoxic chemotherapy – a comparative study”., TAJ: J of Teachers Assoc, vol. 26, pp. 30–37, Nov. 2018, doi: 10.3329/taj.v26i0.37583.